U.S. judge approves $700 million in Abbott Depakote fines, costs
WASHINGTON (Reuters) - A federal judge on Tuesday sentenced Abbott Laboratories Inc to pay $700 million in fines and other costs for illegal marketing of its drug Depakote, in connection with a previously announced settlement, the U.S. Justice Department said.
The pharmaceutical maker said in May it would plead guilty to a misdemeanor violation of misbranding.
Under terms announced then, Abbott agreed to pay $800 million in a civil settlement, a $700 million criminal penalty and $100 million to U.S. states to resolve consumer protection matters.
(Reporting by David Ingram; Editing by Gerald E. McCormick)
- Special Report: Thailand secretly supplies Myanmar refugees to trafficking rings |
- UPDATE 2-China bars banks from bitcoin transactions
- The 10 Most Corrupt and Least Corrupt Countries in the World
- Obama says he's not allowed iPhone for 'security reasons'
- Ford launches new global Mustang to buoy brand, boost margins